Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Société Française des Cancers de l'Enfant (SFCE).
Bourdeaut F, de Carli E, Timsit S, Coze C, Chastagner P, Sarnacki S, Delattre O, Peuchmaur M, Rubie H, Michon J; Neuroblastoma Committee of the Société Française des Cancers et Leucémies de l'Enfant et de l'Adolescent. Bourdeaut F, et al. Among authors: chastagner p. Pediatr Blood Cancer. 2009 May;52(5):585-90. doi: 10.1002/pbc.21912. Pediatr Blood Cancer. 2009. PMID: 19143025
Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology.
Laithier V, Grill J, Le Deley MC, Ruchoux MM, Couanet D, Doz F, Pichon F, Rubie H, Frappaz D, Vannier JP, Babin-Boilletot A, Sariban E, Chastagner P, Zerah M, Raquin MA, Hartmann O, Kalifa C; French Society of Pediatric Oncology. Laithier V, et al. Among authors: chastagner p. J Clin Oncol. 2003 Dec 15;21(24):4572-8. doi: 10.1200/JCO.2003.03.043. J Clin Oncol. 2003. PMID: 14673044
High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
Laprie A, Michon J, Hartmann O, Munzer C, Leclair MD, Coze C, Valteau-Couanet D, Plantaz D, Carrie C, Habrand JL, Bergeron C, Chastagner P, Défachelles AS, Delattre O, Combaret V, Bénard J, Pérel Y, Gandemer V, Rubie H; Neuroblastoma Study Group of the French Society of Pediatric Oncology. Laprie A, et al. Among authors: chastagner p. Cancer. 2004 Sep 1;101(5):1081-9. doi: 10.1002/cncr.20453. Cancer. 2004. PMID: 15329919 Free article.
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
Valteau-Couanet D, Michon J, Boneu A, Rodary C, Perel Y, Bergeron C, Rubie H, Coze C, Plantaz D, Bernard F, Chastagner P, Bouzy J, Hartmann O. Valteau-Couanet D, et al. Among authors: chastagner p. J Clin Oncol. 2005 Jan 20;23(3):532-40. doi: 10.1200/JCO.2005.03.054. J Clin Oncol. 2005. PMID: 15659499 Clinical Trial.
Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effect.
Urien S, Doz F, Giraud C, Rey E, Gentet JC, Chastagner P, Vassal G, Corradini N, Auvrignon A, Leblond P, Rubie H, Treluyer JM. Urien S, et al. Among authors: chastagner p. Cancer Chemother Pharmacol. 2011 Mar;67(3):597-603. doi: 10.1007/s00280-010-1357-2. Epub 2010 May 20. Cancer Chemother Pharmacol. 2011. PMID: 20490798 Clinical Trial.
A dose-intensive approach (NB96) for induction therapy utilizing sequential high-dose chemotherapy and stem cell rescue in high-risk neuroblastoma in children over 1 year of age.
Monnereau-Laborde S, Munzer C, Valteau-Couanet D, Ansoborlo S, Coze C, Chastagner P, Rubie H, Demeocq F, Stephan JL, Hartmann O, Perel Y. Monnereau-Laborde S, et al. Among authors: chastagner p. Pediatr Blood Cancer. 2011 Dec 1;57(6):965-71. doi: 10.1002/pbc.23232. Epub 2011 Jul 8. Pediatr Blood Cancer. 2011. PMID: 21744481 Clinical Trial.
Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy.
Valteau-Couanet D, Le Deley MC, Bergeron C, Ducassou S, Michon J, Rubie H, Le Teuff G, Coze C, Plantaz D, Sirvent N, Bouzy J, Chastagner P, Hartmann O. Valteau-Couanet D, et al. Among authors: chastagner p. Pediatr Blood Cancer. 2014 Jun;61(6):977-81. doi: 10.1002/pbc.24713. Epub 2013 Aug 23. Pediatr Blood Cancer. 2014. PMID: 23970413 Clinical Trial.
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study.
Di Giannatale A, Dias-Gastellier N, Devos A, Mc Hugh K, Boubaker A, Courbon F, Verschuur A, Ducassoul S, Malekzadeh K, Casanova M, Amoroso L, Chastagner P, Zwaan CM, Munzer C, Aerts I, Landman-Parker J, Riccardi R, Le Deley MC, Geoerger B, Rubie H. Di Giannatale A, et al. Among authors: chastagner p. Eur J Cancer. 2014 Jan;50(1):170-7. doi: 10.1016/j.ejca.2013.08.012. Epub 2013 Sep 7. Eur J Cancer. 2014. PMID: 24021349 Clinical Trial.
235 results